Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
951
State Street SPDR S&P Homebuilders ETF
XHB
$1.41B
| $228M | 0.01% |
1,970,354
+500,413
| +34% | +$52.4M |
2013 Q2
52 quarters
|
|
952
Vanguard ESG US Stock ETF
ESGV
$13.7B
| $228M | 0.01% |
1,721,745
+41,420
| +2% | +$5.28M |
2018 Q3
31 quarters
|
|
953
MGM Resorts International
MGM
$7.36B
| $227M | 0.01% |
4,744,049
-190,762
| -4% | -$7.93M |
2013 Q2
52 quarters
|
|
954
Houlihan Lokey
HLI
$9.1B
| $227M | 0.01% |
1,690,245
+98,236
| +6% | +$14.5M |
2015 Q3
43 quarters
|
|
955
Madison Air Solutions
MAIR
$12.2B
| $226M | 0.01% |
+5,793,130
| New | +$226M |
2026 Q2
0 quarters
|
|
956
EastGroup Properties
EGP
$10.5B
| $226M | 0.01% |
1,114,758
-28,805
| -3% | -$5.77M |
2013 Q2
52 quarters
|
|
957
iShares U.S. Thematic Rotation Active ETF
THRO
$6.97B
| $226M | 0.01% |
5,236,600
-1,570,356
| -23% | -$64.9M |
2024 Q3
7 quarters
|
|
958
Tyson Foods
TSN
$18.8B
| $226M | 0.01% |
3,940,264
+532,907
| +16% | +$33.4M |
2013 Q2
52 quarters
|
|
959
United Microelectronic
UMC
$57.6B
| $225M | 0.01% |
8,285,573
-492,330
| -6% | -$8.42M |
2013 Q2
52 quarters
|
|
960
Invitation Homes
INVH
$15.8B
| $225M | 0.01% |
7,459,843
+617,037
| +9% | +$17.5M |
2017 Q1
37 quarters
|
|
961
SBA Communications
SBAC
$19.4B
| $225M | 0.01% |
1,276,825
+159,696
| +14% | +$32.9M |
2013 Q2
52 quarters
|
|
962
Insulet
PODD
$9.38B
| $225M | 0.01% |
1,479,050
+333,119
| +29% | +$55.5M |
2013 Q2
52 quarters
|
|
963
Donaldson
DCI
$10.1B
| $225M | 0.01% |
2,505,649
+96,084
| +4% | +$8.26M |
2013 Q2
52 quarters
|
|
964
Eaton Vance Income Opportunities ETF
XAGG
$1.36B
| $225M | 0.01% |
4,492,414
+1,801,761
| +67% | +$90.4M |
2025 Q4
2 quarters
|
|
965
Allegion
ALLE
$12.8B
| $225M | 0.01% |
1,598,055
+332,071
| +26% | +$45.1M |
2013 Q4
50 quarters
|
|
966
EchoStar
ECHO
$27.6B
| $224M | 0.01% |
2,209,487
+242,413
| +12% | +$29.6M |
2013 Q2
52 quarters
|
|
967
Lamar Advertising Co
LAMR
$14.9B
| $224M | 0.01% |
1,435,353
+58,996
| +4% | +$8.53M |
2013 Q2
52 quarters
|
|
968
Sanmina
SANM
$11.7B
| $223M | 0.01% |
881,557
-62,527
| -7% | -$13.7M |
2013 Q2
52 quarters
|
|
969
Zimmer Biomet
ZBH
$17B
| $223M | 0.01% |
2,591,503
+561,688
| +28% | +$49.3M |
2013 Q2
52 quarters
|
|
970
Eastman Chemical
EMN
$7.17B
| $223M | 0.01% |
3,330,732
+252,892
| +8% | +$18.5M |
2013 Q2
52 quarters
|
|
971
Celsius Holdings
CELH
$7.23B
| $223M | 0.01% |
7,615,074
+4,815,902
| +172% | +$152M |
2018 Q1
33 quarters
|
|
972
Neurocrine Biosciences
NBIX
$14.5B
| $222M | 0.01% |
1,318,607
+99,411
| +8% | +$14.7M |
2013 Q2
52 quarters
|
|
973
JPMorgan Mortgage-Backed Securities ETF
JMTG
$6.66B
| $222M | 0.01% |
4,381,196
-1,183,187
| -21% | -$60M |
2025 Q2
4 quarters
|
|
974
Halozyme
HALO
$12.5B
| $222M | 0.01% |
2,832,594
+270,285
| +11% | +$18.4M |
2013 Q2
52 quarters
|
|
975
Masco
MAS
$13.6B
| $221M | 0.01% |
2,720,420
-37,436
| -1% | -$2.61M |
2013 Q2
52 quarters
|
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.